Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease

A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials

“…4 Though this latter review 4 also collates data from endoscopy negative reflux disease patients, data from this patient group have not been used in this analysis.…”

“…4 The same drug therapies as for initial therapy were allowed and patients had to have taken at least 12 weeks of continuous therapy. Symptom assessment had to occur within 12 and 52 weeks.…”